Verhamme, Katia

Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study

Li, X., Ostropolets, A., Makadia, R., Shoaibi, A., Rao, G., Sena, A. G., Martinez-Hernandez, E., Delmestri, A., Verhamme, K., Rijnbeek, P. R., et al. (2021) · BMJ

Pharmacovigilance and Adverse Drug ReactionsSARS-CoV-2 and COVID-19 Research

Cited by 219

Hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe): results from a worldwide point prevalence survey in 69 countries

Pauwels, I., Versporten, A., Drapier, N., Vlieghe, E., Goossens, H., the Global-PPS network, Koraqi, A., Hoxha, I., Tafaj, S., Cornistein, W., et al. (2021) · Journal of Antimicrobial Chemotherapy

Antibiotic Use and ResistanceAntibiotic Resistance in Bacteria

Cited by 175

Prevalence, Incidence, and Lifetime Risk for the Development of COPD in the Elderly

van Durme, Y. M. T. A., Verhamme, K. M. C., Stijnen, T., van Rooij, F. J. A., Van Pottelberge, G. R., Hofman, A., Joos, G. F., Stricker, B. H. C., & Brusselle, G. G. (2009) · Chest

Chronic Obstructive Pulmonary Disease (COPD) ResearchSmoking Behavior and Cessation

Cited by 151

Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID ‐19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries

Burn, E., Li, X., Kostka, K., Stewart, H. M., Reich, C., Seager, S., Duarte‐Salles, T., Fernandez‐Bertolin, S., Aragón, M., Reyes, C., et al. (2022) · Pharmacoepidemiology and Drug Safety

Heparin-Induced Thrombocytopenia and ThrombosisPharmacovigilance and Adverse Drug Reactions

Cited by 43

Pediatric drug safety signal detection: a new drug–event reference set for performance testing of data-mining methods and systems

Osokogu, O. U., Fregonese, F., Ferrajolo, C., Verhamme, K., de Bie, S., Jong, G. ’., Catapano, M., Weibel, D., Kaguelidou, F., Bramer, W. M., et al. (2015) · Drug Safety

Pharmacovigilance and Adverse Drug ReactionsPharmaceutical studies and practices

Cited by 31